CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 57 enrolled
Drug / intervention
Liposomal bupivacaine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02570022
NCT02570022Phase 4Completed
CompareCT.gov

Liposomal Bupivacaine Versus Interscalene Nerve Block for Pain Control After Shoulder Arthroplasty: A Prospective Randomized Trial

Henry Ford Health System·interventional·Posted Oct 7, 2015·Updated Oct 13, 2016

In Brief

A Phase 4 clinical trial evaluating Liposomal bupivacaine, Inter-scalene nerve block, and 1 other intervention for Pain. Completed, enrolled 57 participants across 1 site.

Detailed Summary

This is a randomized, single blinded, standard of care controlled clinical trial. All adult patients over eighteen desiring shoulder arthroplasty will be eligible. The study compares pain control and opioid consumption in patients undergoing shoulder arthroplasty between patients receiving liposomal bupivacaine and those who underwent a preoperative inter-scalene nerve block.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 7, 2015
Enrollment StartOct 1, 2014
Primary CompletionMay 1, 2016
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.7 years ago

Interventions

Liposomal bupivacainedrug

Local infiltration of liposomal bupivacaine

Inter-scalene nerve blockprocedure

Pre-operative inter-scalene nerve block

Ropivacainedrug

Ropivicaine was used for the inter-scalene nerve block.